Mei Gan
Yulin, 537000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DHRS2 as a Novel Thalidomide Target Regulating Mitophagy and Inflammation in Head and Neck Squamous Cell Carcinoma.
Journal: Current medicinal chemistry
Published: October 20, 2025
Evaluating the potential causal relationship between carnitine-related metabolites and breast cancer: a Mendelian randomization and transcriptomic analysis.
Journal: Archives of medical science : AMS
Published: October 16, 2025
Integrated single-cell and transcriptomic analysis of CD8+CD101+TIM3+ T cells in hepatocellular carcinoma: implications for tumor microenvironment and prognostic modeling.
Journal: Translational cancer research
Published: July 27, 2025
Thalidomide attenuates radiation-induced apoptosis and pro-inflammatory cytokine secretion in oral epithelial cells by promoting LZTS3 expression.
Journal: Journal of translational medicine
Published: July 18, 2024
Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.
Journal: Reproductive health
Published: April 18, 2024
Integrated analysis of the lncRNA-miRNA-mRNA ceRNA network in nasopharyngeal carcinoma.
Journal: Translational cancer research
Published: February 19, 2024
Healthcare quality and safety assessment based on annual scorekeeping.
Journal: Frontiers in public health
Published: May 06, 2022
High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas.
Journal: Journal of Cancer
Published: August 03, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026